Monte Rosa Therapeutics's total assets for Q1 2026 were $736.43M, an increase of 64.14% from the previous quarter. GLUE total liabilities were $214.51M for the fiscal quarter, a -0.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.